Search Results - "Oertel, Maryann D"
-
1
Fondaparinux and the Management of Heparin-Induced Thrombocytopenia: The Journey Continues
Published in The Annals of pharmacotherapy (01-10-2009)“…Objective: To review the available literature addressing the role of fondaparinux in the management of heparin-induced thrombocytopenia (HIT). Data Sources:…”
Get full text
Journal Article -
2
Allopurinol as Adjuvant Therapy in Poorly Responsive or Treatment Refractory Schizophrenia
Published in The Annals of pharmacotherapy (01-12-2006)“…Objective: To review the available literature evaluating the effectiveness of allopurinol for poorly responsive or treatment refractory schizophrenia. Data…”
Get full text
Journal Article -
3
Reflections on the use of electronic health record data for clinical research
Published in Health informatics journal (01-06-2009)“…The adoption of electronic health records (EHRs) offers the potential to improve the delivery, quality, and continuity of clinical care, but widespread use has…”
Get more information
Journal Article -
4
Evaluation of Outcomes in Converting from Intravenous Ondansetron to Oral Granisetron: An Observational Study
Published in The Annals of pharmacotherapy (01-01-2001)“…OBJECTIVE: To describe a systematic evaluation of the outcomes associated with revising institutional guidelines for the prevention of acute…”
Get full text
Journal Article -
5
Anagrelide, a selective thrombocytopenic agent
Published in American journal of health-system pharmacy (01-10-1998)“…The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosage and administration of anagrelide are reviewed. Anagrelide is a selective…”
Get full text
Journal Article -
6
RespiGam: an RSV immune globulin
Published in Pediatric nursing (01-11-1996)“…Respiratory syncytial virus immune globulin has been shown to prevent or attenuate RSV lower respiratory tract infection in infants under 24 months of age with…”
Get more information
Journal Article -
7
Synagis: an anti-RSV monoclonal antibody
Published in Pediatric nursing (01-09-1999)“…Palivizumab is a new anti-RSV monoclonal antibody product indicated for the prevention of serious lower respiratory tract disease caused by RSV in pediatric…”
Get more information
Journal Article -
8
Ciprofloxacin-induced toxic epidermal necrolysis
Published in The Annals of pharmacotherapy (01-03-1996)Get more information
Journal Article